The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Indirect treatment (tx) comparison of teclistamab (tec) in MajesTEC-1 versus physician’s choice of therapy in the long-term follow-up of the CASTOR, POLLUX, EQUULEUS, and APOLLO trials in patients (pts) with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).

Maria-Victoria  Mateos

Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda

Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda

Ajai  Chari

Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda

Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda

Saad Zafar  Usmani

Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda

Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda

Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics

Hartmut  Goldschmidt

Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Chugai Pharma; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi

Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst)

Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Incyte (Inst); Janssen (Inst); Molecular Partners (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)

Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi

Other Relationship - Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Sanofi (Inst)

Katja  Weisel

Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda

Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda

Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)

Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda

Keqin  Qi

Employment - Janssen

Stock and Other Ownership Interests  - Janssen

Anil  Londhe

Employment - Johnson & Johnson

Stock and Other Ownership Interests  - Johnson & Johnson

Sandhya  Nair

Employment - Janssen Research & Development

Stock and Other Ownership Interests  - Johnson & Johnson/Janssen

Xiwu  Lin

Employment - Johnson & Johnson/Janssen

Stock and Other Ownership Interests  - Johnson & Johnson/Janssen

Lixia  Pei

Employment - Janssen Oncology

Stock and Other Ownership Interests  - Janssen Oncology

Eric  Ammann

Employment - Johnson & Johnson/Janssen

Stock and Other Ownership Interests  - Johnson & Johnson/Janssen

Rachel  Kobos

Employment - Janssen

Stock and Other Ownership Interests  - Janssen

Jennifer  Smit

Employment - Johnson & Johnson/Janssen

Stock and Other Ownership Interests  - Johnson & Johnson/Janssen

Travel, Accommodations, Expenses - Johnson & Johnson/Janssen

Trilok V.  Parekh

Employment - Johnson & Johnson; Lilly (I)

Stock and Other Ownership Interests  - Johnson & Johnson; Lilly (I)

Mary  Slavcev

Employment - Janssen

Stock and Other Ownership Interests  - Janssen

Patents, Royalties, Other Intellectual Property - Mediphage (I)

Philippe  Moreau

Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi

Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi